Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.
about
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerAdvances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized MedicineTrastuzumab Administration in Patients with Metastatic Breast Cancer - Experience of a Large University Breast CenterSerial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM StudyBreast Cancer Update 2014 - Focus on the Patient and the Tumour.The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimensPrognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survivalComprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial.Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyCost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidenceScreening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.Long-term cost-effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective.MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.[Molecular pathology for breast cancer: Importance of the gene expression profile].FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
P2860
Q26801108-21C51E87-AB19-49E3-8D6B-4C5B1E5ACA6FQ27001994-932870CB-27FE-4C72-9F5D-855D77405FB2Q33800955-7774ABB3-B8CD-4457-8453-37124B1F494CQ34485182-09E3CFE2-EA3B-402D-ADB9-D287926239D1Q34657656-1B41A147-9997-4456-9BBF-E321C615E43CQ34764981-CFEEDFDE-F21F-4417-B77E-69091760819FQ35180940-768B191F-C121-4A9E-AD04-DD2FAF0366F2Q35619770-8948C65C-E336-4832-B18D-D65C75BB29FFQ35807025-627D5A92-FBCB-4419-B454-E34DCAB4493BQ35905187-C085CD1F-5D28-4824-B1B5-438273A6EC94Q36070547-0F13A607-6698-4D94-9566-2B77625D1F25Q36109274-8BFEB0E7-0CA9-41B5-A0D6-9D7AB0DB05A6Q36111215-6905A615-510E-43E3-AA3E-B2AC39BF6A14Q36132415-E48DEB27-E899-4FBE-B406-F5978160755DQ36151341-F3CE08E2-7AAC-4A89-8050-FC5D7EBBFD05Q36339076-8B865337-A96E-4360-96CE-7630956863F2Q36462893-28086B07-8500-40EA-9D03-1D8FED2A93BAQ37746911-EB61D24A-D961-4F24-BFB1-A5DD79F1DCD8Q41075349-EF900F66-E432-4DCF-8611-EF8428A19416Q41545259-8BAD0929-B680-4B38-94A2-4A5769FA5EEFQ47205521-49906A34-5F03-4E31-A65B-1DD9D301AF5FQ49843589-91C6BD3F-DAA6-49FF-A5B3-B43901143D51Q52868166-4BC92DB7-A3F5-45E2-A167-CF3C8EAB3A59Q53607061-64F602CE-FAF0-459E-AB08-FC92E90C2004
P2860
Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multigene Assays for Classific ...... ckground and Clinical Utility.
@en
Multigene Assays for Classific ...... ckground and Clinical Utility.
@nl
type
label
Multigene Assays for Classific ...... ckground and Clinical Utility.
@en
Multigene Assays for Classific ...... ckground and Clinical Utility.
@nl
prefLabel
Multigene Assays for Classific ...... ckground and Clinical Utility.
@en
Multigene Assays for Classific ...... ckground and Clinical Utility.
@nl
P2093
P2860
P356
P1476
Multigene Assays for Classific ...... ackground and Clinical Utility
@en
P2093
A Schneeweiss
P2860
P304
P356
10.1055/S-0033-1350831
P577
2013-09-01T00:00:00Z